Shares of Bioventix PLC (LON:BVXP – Get Free Report) reached a new 52-week low during trading on Wednesday . The stock traded as low as GBX 1,450 and last traded at GBX 1,525, with a volume of 7868 shares traded. The stock had previously closed at GBX 1,525.
Bioventix Stock Performance
The stock has a market capitalization of £79.68 million, a P/E ratio of 10.64 and a beta of 0.53. The business has a 50-day moving average price of GBX 1,733.58 and a 200 day moving average price of GBX 2,025.84.
Bioventix Company Profile
Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants. It also provides contract SMAs and recombinant services. Bioventix PLC was incorporated in 2003 and is based in Farnham, United Kingdom.
Featured Articles
- Five stocks we like better than Bioventix
- The gold chart Wall Street is terrified of…
- What a Former CIA Agent Knows About the Coming Collapse
- Elon Musk already made me a “wealthy man”
- Unlocked: Elon Musk’s Next Big IPO
- 1,500 Banks Just Handed the Fed Your Bank Account
Receive News & Ratings for Bioventix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioventix and related companies with MarketBeat.com's FREE daily email newsletter.
